Please login to the form below

Not currently logged in
Email:
Password:

Restasis

This page shows the latest Restasis news and features for those working in and with pharma, biotech and healthcare.

Shire rebuffs Takeda bids, as Allergan bows out

Shire rebuffs Takeda bids, as Allergan bows out

a bid to reduce costs as it faces tougher competition for dry eye treatment Restasis, its second-biggest product after Botox.

Latest news

More from news
Approximately 3 fully matching, plus 7 partially matching documents found.

Latest Intelligence

  • The good, the bad and the ugly The good, the bad and the ugly

    In second position, Allergan experienced modest sales growth of 2.3%. “Allergan’s main ophthalmology product - Restasis - is the go-to treatment for dry eye, but is due to go off

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Indians scalp cowboys in patent war

    To defend its dry eye treatment Restasis (ciclosporin) against generic competition, Allergan has transferred the patent to the St Regis Mohawks, who have 'sovereign immunity' under US law. ... The Restasis case is not so much an example of 'evergreening'

  • Indians scalp cowboys in patent war

    To defend its dry eye treatment Restasis (ciclosporin) against generic competition, Allergan has transferred the patent to the St Regis Mohawks, who have 'sovereign immunity' under US law. ... The Restasis case is not so much an example of 'evergreening'

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PharmiWeb Solutions

PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics